In November 2015, the American Medical Association adopted a policy that petitions for the ban on direct-to-consumer (DTC) advertising of prescription drugs and medical devices. According to their press release, the policy is aimed at driving solutions to make prescription drugs more affordable. The United States and New Zealand are the only two developed countries in the world that allow direct-to-consumer advertising of prescription drugs. How would this ban affect health and life sciences? The following infographic illustrates the many ways this ban could shape the future of the pharma industry.
We would never get this much data from a face-to-face on a particular topic. And we’re doing this every month!Commercial Lead